Similarly, targeted paclitaxel delivery to breast cancer MCF-7 cells with anti-CD133 mAb targeting nanoparticles significantly reduced colony-forming potential and mammosphere formation compared to paclitaxel alone [257]. Here, PROM1 is linked to breast cancer.